Search Results
Mar 09, 2026, 09:00 ET NATUREPEDIC SELECTED AS A GOOD HOUSEKEEPING 2026 BEDDING AWARD WINNER
Made with authentic Supima cotton, these organic cotton bed sheets are woven from extra-long staple fibers prized for their softness and rare strength. Representing just 1% of the world's cotton, these Supima cotton sheets start with organic cotton cultivated on Native American family farms,
More news about: Naturepedic
Mar 09, 2026, 08:04 ET South University, Tampa PAs Partner with Calvary Community Clinic to Secure Life-Saving Cancer Treatment
including laboratory testing, biopsies, CT scans, and a full-body PET scan. The patient was diagnosed with B-cell Leukemia localized to the tumor – a rare presentation – and underwent inpatient and outpatient chemotherapy treatment. She is currently in remission living near family in Sarasota, Florida."At
More news about: South University
Mar 09, 2026, 08:00 ET ITF Therapeutics LLC Presents New Data and Analyses on Givinostat for Treatment of Duchenne Muscular Dystrophy at 2026 MDA Clinical and Scientific Conference
commercialization with proven success in many therapeutic areas including immuno-oncology, gynecology, neurology, cardiovascular disease, and rare diseases. Italfarmaco's rare disease unit includes programs in Duchenne muscular dystrophy, Becker muscular dystrophy, amyotrophic lateral sclerosis, and polycythemia
More news about: ITF Therapeutics LLC
Mar 09, 2026, 04:52 ET My Plates Launches Two Letter Texas Plate Auction!
Twenty-Five Rare 2-Letter Plate Messages Available!AUSTIN, Texas, March 9, 2026 /PRNewswire/ -- Up for grabs are twenty-five rare two-letter plate messages. If you are a registered nurse, RN will
More news about: My Plates
Mar 09, 2026, 02:28 ET Leads Biolabs' Opamtistomig (LBL-024) Enrolls First ESCC Patient, Exploring Dual PD-L1/4-1BB Mechanism for Superior Survival Benefits in China's High-Incidence Cancer
monotherapy, and it holds promise to become the first approved therapy specifically for extrapulmonary neuroendocrine carcinoma (EP-NEC)—a rare malignancy with substantial unmet clinical need.Developed using Leads Biolabs' proprietary X-Body bispecific platform, Opamtistomig features
More news about: Leads Biolabs
Mar 08, 2026, 12:00 ET RARE Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages RARE Investors with Losses to Contact the Firm
Did you buy RARE common stock between August 3, 2023, and December 26, 2025?Affected Ultragenyx Pharmaceutical Inc. Investor SummaryWho: Ultragenyx Pharmaceutical Inc. (
More news about: Kessler Topaz Meltzer & Check, LLP
Mar 08, 2026, 06:08 ET GEEKOM A5 Pro 2026 Edition Sets New Benchmark as the Best $600 Mini PC
Pro 2026 Edition arrives as one of the most compelling compact desktops to date, earning its position as the best $600 mini PC in 2026 thanks to a rare blend of high performance that breezes through all daily tasks, solid build quality that withstand at least 5 years of intensive use, and a 3-year warranty
More news about: GEEKOM
Mar 08, 2026, 06:08 ET GEEKOM A5 Pro 2026 Edition Sets New Benchmark as the Best $600 Mini PC
Pro 2026 Edition arrives as one of the most compelling compact desktops to date, earning its position as the best $600 mini PC in 2026 thanks to a rare blend of high performance that breezes through all daily tasks, solid build quality that withstand at least 5 years of intensive use, and a 3-year warranty
More news about: GEEKOM
Mar 08, 2026, 06:08 ET Le GEEKOM A5 Pro 2026 Edition établit une nouvelle référence en tant que meilleur mini PC à 600 $
des ordinateurs de bureau compacts les plus performants à ce jour, gagnant sa position de meilleur mini PC au prix de 600 $ en 2026 grâce à un mélange rare de haute performance qui facilite toutes les tâches quotidiennes, à une qualité de construction solide qui résiste à au moins 5 ans d'utilisation intensive
More news about: GEEKOM
Mar 08, 2026, 06:04 ET Global Times: Bluer skies, greener waters, healthier people: Healthy China as the NPC deputies see it
in Shanxi have seen environmental improvements. Friends in Linfen city say the air there has also gotten better, and now blue skies are no longer a rare sight," Wang said with a smile.Before coming to Beijing this time, she had specially printed two photos of Taiyuan to bring with her. "With the
More news about: Global Times
Mar 07, 2026, 13:10 ET INVESTOR ALERT: Soleno Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law
[email protected] ALLEGATIONS: Soleno is a biopharmaceutical company focused on developing novel therapeutics for the treatment of rare diseases. At the time of the Soleno class action lawsuit's filing, Soleno's only commercial product is diazoxide choline extended-release tablets
More news about: Robbins Geller Rudman & Dowd LLP
Mar 07, 2026, 11:45 ET Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
N.V. CLASS ACTION LAWSUIT - COMPLAINT ALLEGATION SUMMARY:uniQure is a biotechnology company developing gene therapies for rare diseases, including Huntington's disease (HD). uniQure's leading drug candidate is AMT-130, a novel gene therapy being developed to slow the progression
More news about: Kessler Topaz Meltzer & Check, LLP
Mar 06, 2026, 21:49 ET Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE
Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NasdaqGS: RARE), if they purchased or otherwise acquired the Company's shares between August 3, 2023 and December 26, 2025, inclusive (the "Class Period"). This action
More news about: ClaimsFiler
Mar 06, 2026, 15:43 ET Eightpoint Unveils the Next Evolution of NewsNow Home, Bringing Smarter Hyperlocal News to Android
patterns, transforming the home screen into a more intelligent daily starting point. "Information today is abundant, but relevance is increasingly rare," said Deniz Gezgin, Eightpoint CEO. "Our vision is to build products that understand what matters to each user and deliver it at the right moment. By
More news about: Eightpoint
Mar 06, 2026, 15:10 ET CGTN : La Chine se prépare pour un démarrage solide de son prochain plan quinquennal et ouvre des perspectives au niveau mondial
court-termisme ambiant, le 15e plan stratégique annuel de la Chine, dont le projet a été soumis à l'examen de la session de l'ANP jeudi, continue d'offrir un rare degré de confiance et de cohérence stratégiques.Au cours des cinq prochaines années, la Chine espère maintenir la croissance de son PIB dans
More news about: CGTN
Mar 06, 2026, 13:20 ET Los Angeles Jury Returns $12.75M Talc-Asbestos Cancer Verdict Against Port Jervis Laboratories, Inc. (formerly Kolmar Labs)
important measure of justice and some comfort to Dr. Flores Soto's husband and family after the devastating loss they have endured."Mesothelioma is a rare and aggressive cancer caused solely by asbestos exposure. While many mesothelioma victims are exposed to asbestos in industrial workplaces, consumers can
More news about: Waters Kraus Paul & Siegel
Mar 06, 2026, 11:15 ET Strategically Minded Miners Targeting the Metals the World Cannot Build Without
year as EVs, power grids, and data centres consume more metal than mines can deliver[1][2]. Rare earths and nickel face the same squeeze. The United States is 100% import-dependent on rare earth elements and more than half-dependent on foreign nickel, according to the U.S. Geological Survey[3].
More news about: USA News Group
Mar 06, 2026, 11:12 ET Are SEM, FARM, TMRC Obtaining Fair Deals for their Shareholders?
more about your rights and options.Texas Mineral Resources Corp. (OTCQB: TMRC)'s sale to USA Rare Earth, Inc. for 3,823,328 shares of USA Rare common stock. If you are a Texas Mineral shareholder,
More news about: Halper Sadeh LLP
Mar 06, 2026, 10:36 ET Servier et Day One Biopharmaceuticals annoncent un accord d'acquisition qui renforce le portefeuille de Servier dans les cancers rares
2030 et nous sommes convaincus que la combinaison de nos expertises permettra d'accélérer l'innovation au bénéfice des personnes vivant avec un cancer rare. »« Le parcours reconnu de Servier dans les cancers rares et son engagement en faveur du développement de thérapies ciblées en font le
More news about: Servier; Day One Biopharmaceuticals
Mar 06, 2026, 10:29 ET Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio
with our 2030 ambition, and we believe that combining our expertise will accelerate innovation for people living with a rare cancer.""Servier's successful track record in rare cancers and its commitment to advancing targeted therapies makes it the ideal home for our portfolio as part of Day One's
More news about: Servier; Day One Biopharmaceuticals
Mar 06, 2026, 10:20 ET Helium Market to Reach USD 9.47 Billion by 2032; Maximize Market Research Forecasts 8.29% CAGR Fueled by Global Semiconductor Fab Expansion
Following the late 2025 landmark discovery at the Topaz Project in Minnesota, 2026 has seen accelerated testing of high-concentration helium-3. This rare isotope is essential for Quantum Computing cryostats, positioning Minnesota as a global hub for next-generation cooling technology.Access
More news about: Maximize Market Research Pvt. Ltd.
Mar 06, 2026, 09:20 ET U.S. Defense Manufacturers Face A Rare Earth Supply Squeeze - OilPrice.com Market Commentary
Hoidas Lake rare earth project in Saskatchewan, anchoring primary resource exposure inside Canada. In Greenland, it has signed a long-term non-binding letter of intent covering approximately 15% of future production from the Tanbreez rare earth project–one of the largest heavy and medium rare earth deposits
More news about: OilPrice.com
Mar 06, 2026, 09:15 ET Elevate Appoints Megan Fenlon as Chief Operations Officer
"Megan brings the rare combination of healthcare scale, fintech rigor, and analytics leadership we need as we scale our platform," said Brian Cosgray, CEO of
More news about: Elevate
Mar 06, 2026, 08:58 ET RARE CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ultragenyx Investors of Securities Class Action Deadline on April 6, 2026
leading national securities law firm, is investigating potential claims against Ultragenyx Pharmaceutical Inc ("Ultragenyx" or the "Company") (NASDAQ: RARE) and reminds investors of the April 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed
More news about: Faruqi & Faruqi, LLP
Mar 06, 2026, 08:41 ET Strax Networks Appoints Hall of Famer and Entrepreneur Frank Thomas as Strategic Advisor
commercial execution aligns with Strax's mission to build secure, scalable AI-powered engagement infrastructure for enterprise markets."Frank brings a rare combination of performance, leadership, and business acumen," said Eric Singleton, co-Founder and Chief Executive Officer of Strax Networks. "As we
More news about: Strax Networks Inc.